India’s first indigenously produced Covid-19 vaccine, Covaxin, has shown an interim efficacy of 81% in Phase III trials for preventing the virus. Covaxin has been developed in India jointly b
As Mumbai is on alert with Cyclone Tauktae predicted to cause very heavy rains, the civic authorities have suspended the vaccination programme for Monday, and the special drive would be now held fr
